Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases and is indicated for the treatment of:,? breast cancer,? gastric cancer,? ovarian cancer,? small cell lung cancer,? lymphoma (non-hodgkin?s lymphoma),? advanced/metastatic soft tissue sarcoma,? superficial bladder cancer (tis; ta).,in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium lactate, quantity: 3.17 g/l; sodium chloride, quantity: 6 g/l; potassium chloride, quantity: 0.4 g/l; calcium chloride dihydrate, quantity: 0.27 g/l - injection, intravenous infusion - excipient ingredients: water for injections - compound sodium lactate (hartmann's solution) injection is used for intrvenous fluid and electrolyte replacement, as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency, and as a vehicle for intravenous drug delivery, if the drugs are compatible with the solutions.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium lactate, quantity: 3.17 g/l; sodium chloride, quantity: 6 g/l; potassium chloride, quantity: 0.4 g/l; calcium chloride dihydrate, quantity: 0.27 g/l - injection, intravenous infusion - excipient ingredients: water for injections - compound sodium lactate (hartmann's solution) injection is used for intrvenous fluid and electrolyte replacement, as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency, and as a vehicle for intravenous drug delivery, if the drugs are compatible with the solutions.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - sodium chloride, quantity: 5.786 g/l; chloride, quantity: 102.5 mmol/l; calcium chloride dihydrate, quantity: 0.1838 g/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; magnesium, quantity: 0.5 mmol/l; lactate, quantity: 35 mmol/l; sodium lactate, quantity: 3.925 g/l; glucose monohydrate, quantity: 25 g/l; calcium, quantity: 1.25 mmol/l; sodium, quantity: 134 mmol/l - solution, irrigation - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - chloride, quantity: 102.5 mmol/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; lactate, quantity: 35 mmol/l; magnesium, quantity: 0.5 mmol/l; calcium, quantity: 1.25 mmol/l; calcium chloride dihydrate, quantity: 0.1838 g/l; sodium chloride, quantity: 5.786 g/l; glucose monohydrate, quantity: 46.75 g/l; sodium lactate, quantity: 3.925 g/l; sodium, quantity: 134 mmol/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - chloride, quantity: 102.5 mmol/l; lactate, quantity: 35 mmol/l; sodium chloride, quantity: 5.786 g/l; calcium, quantity: 1.25 mmol/l; sodium, quantity: 134 mmol/l; sodium lactate, quantity: 3.925 g/l; calcium chloride dihydrate, quantity: 0.1838 g/l; magnesium, quantity: 0.5 mmol/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; glucose monohydrate, quantity: 46.75 g/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - sodium chloride - solvent for parenteral use - 0.9 %v/w - electrolyte solutions; sodium chloride

Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - sodium acetate, trihydrate, sodium chloride, potassium chloride, magnesium chloride, hexahydrate - solution for infusion - sodium acetate trihydrate 2.32 g sodium chloride 3.01 g potassium chloride 0.15 g magnesium chloride hexahydrate 0.15 g - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - sodium acetate, trihydrate, sodium chloride, potassium chloride, magnesium chloride, hexahydrate - solution for infusion - sodium acetate trihydrate 4.63 g sodium chloride 6.02 g potassium chloride 0.30 g magnesium chloride hexahydrate 0.30 g - blood substitutes and perfusion solutions

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - potassium chloride; sodium chloride - solution for infusion - 0.15% w/v + 0.9% w/v percent weight/volume - solutions affecting the electrolyte balance; electrolytes